↓ Skip to main content

Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas

Overview of attention for article published in BMC Clinical Pathology, March 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas
Published in
BMC Clinical Pathology, March 2013
DOI 10.1186/1472-6890-13-9
Pubmed ID
Authors

Sveinung W Sorbye, Thomas K Kilvaer, Andrej Valkov, Tom Donnem, Eivind Smeland, Khalid Al-Shibli, Roy M Bremnes, Lill-Tove Busund

Abstract

S-phase kinase-associated protein 2 (Skp2) is a member of mammalian F-box proteins. The purpose of this study is to clarify the prognostic significance of expression of Skp2 related to gender, estrogen receptor (ER) and progesterone receptor (PGR) in soft tissue sarcomas (STS). Skp2 has been demonstrated to display an oncogenic function since its overexpression has been observed in many human cancers. Optimized treatment of STS requires better identification of high-risk patients who will benefit from adjuvant therapy. The prognostic significance of Skp2 related to ER and PGR in STS has not been sufficiently investigated.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Norway 1 11%
Unknown 8 89%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 33%
Student > Doctoral Student 3 33%
Student > Ph. D. Student 2 22%
Researcher 1 11%
Readers by discipline Count As %
Medicine and Dentistry 7 78%
Biochemistry, Genetics and Molecular Biology 1 11%
Unknown 1 11%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2013.
All research outputs
#20,185,720
of 22,701,287 outputs
Outputs from BMC Clinical Pathology
#94
of 116 outputs
Outputs of similar age
#171,784
of 196,095 outputs
Outputs of similar age from BMC Clinical Pathology
#8
of 9 outputs
Altmetric has tracked 22,701,287 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 116 research outputs from this source. They receive a mean Attention Score of 3.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 196,095 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one.